CDKN2A and cancer: Additionally, homologous deletion or loss of heterozygosity on the CDKN2a locus has also been frequently reported in numerous cancers, including breast, bladder, liver, lung, oral, prostate, and kidney cancer [97,102,106,107,108,109,110,111,112].